GILD
GILD
NASDAQ · Biotechnology

Gilead Sciences Inc

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$138.12
-0.02 (-0.01%)
Analyst Consensus
Strong Buy
37
Analysts
Very High
Coverage
Buy 30 81%
Hold 7 19%
Sell 0 0%
Price Target
Analyst Price Target +162.6% upside
Low Target $213.16
Average Target $362.68
High Target $477.67
Current Price $138.12
Current
$138.12
Target
$362.68
$213.16 $362.68 avg $477.67
Scenario Analysis
Bear Case
$213.16
54.3%
Low target
Base Case
$362.68
+162.6%
Avg target
Bull Case
$477.67
+245.8%
High target
Risk/Reward
4.5x
Highly favorable
Price in Context
52-Week High
$157.29
-12.2% from high
52-Week Low
$108.46
+27.3% from low
50-Day SMA
$131.98
+4.7% vs SMA
200-Day SMA
$118.67
+16.4% vs SMA
RSI (14)
65.1
Neutral
Target vs 52W High
$362.68
+130.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 +3.2%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.8%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 37 81% $438.34 -13.8%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -43.8%
BIIB
Biogen Inc
 Buy 43 67% $91.45 -56.6%